Live Analyst Rating Changes 1515 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Carl Byrnes
NORT
Carl Byrnes
Northland Securities
Wall Street Analyst
★☆☆☆☆
#2505
on 13Foresight · ranked by our own returns
33%
Success Rate
-22.1%
Average Return
7 of 21 calls profitable · -35.5% vs benchmark
🔒 3-year track record is Pro. Showing 1-year — upgrade.
📈 Across the calls we could measure, roughly 33% of Carl Byrnes's ratings turned a profit when each position was held for 1 year — averaging -22.1% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

58 Buy 1 Hold 0 Sell
Carl's Stock Coverage 22 ratings · 2026-06-19
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return
CNTB
Connect Biopharma Holdings
 Apr 24, 2026 BUY Strong Buy
+226.3% avg upside
11 analysts
$7.50
275.04% Upside
 -7.1%
MDXG
MiMedx Group
 Apr 17, 2026 BUY Strong Buy
+185.0% avg upside
17 analysts
$6.00
63.47% Upside
 +5.4%
SPRY
ARS Pharmaceuticals
 Apr 15, 2026 BUY Strong Buy
+121.7% avg upside
12 analysts
$25.00
159.07% Upside
 -7.4%
RCEL
Avita Medical
 Mar 26, 2026 BUY Strong Buy
+155.9% avg upside
10 analysts
$10.00
149.39% Upside
 +16.1%
BLFS
BioLife Solutions
 Mar 24, 2026 BUY Strong Buy
+13.0% avg upside
17 analysts
$34.00
30.48% Upside
 +21.6%
TLSI
TriSalus Life Sciences
 Mar 23, 2026 BUY Strong Buy
+129.2% avg upside
8 analysts
$8.00
96.13% Upside
 -31.6%
MDAI
Spectral AI
 Mar 19, 2026 BUY Strong Buy
+147.2% avg upside
3 analysts
$6.00
229.60% Upside
 +33.1%
SNWV
Sanuwave Health
 Mar 16, 2026 BUY Strong Buy
+270.4% avg upside
3 analysts
$55.00
497.23% Upside
 -24.1%
INDV
Indivior
 Feb 27, 2026 BUY Strong Buy
+12.8% avg upside
8 analysts
$50.00
30.59% Upside
 +15.9%
BWAY
Brainsway
 Jan 22, 2026 BUY Strong Buy
-11.3% avg upside
9 analysts
$15.00
0.68% Upside
 +23.1%
ALVO
Alvotech
 Nov 14, 2025 BUY Buy
+104.1% avg upside
6 analysts
$10.00
155.19% Upside
 -39.9%
HRTX
Heron Therapeutics
 Nov 05, 2025 BUY Strong Buy
+6439.5% avg upside
21 analysts
$4.00
858.08% Upside
 -61.3%
COCH
Envoy Medical
 Aug 28, 2025 BUY Strong Buy
+901.0% avg upside
5 analysts
$5.00
688.58% Upside
 -41.6%
ESPR
Esperion
 May 08, 2024 HOLD Buy
+701.2% avg upside
22 analysts
$3.00
4.81% Downside
 -56.4%
AMRN
Amarin
 Jul 19, 2023 HOLD Buy
-47.2% avg upside
18 analysts
$1.25
92.14% Downside
 -27.8%
CDIO
Cardio Diagnostics Holdings
 May 22, 2023 BUY Strong Buy
+152.6% avg upside
2 analysts
$8.00
304.06% Upside
 -53.3%
NBRVF
Nabriva Therapeutics
 Jan 06, 2023 SELL Buy
+13374900.0% avg upside
9 analysts
$1.00
999899.98% Upside
 ·
ARDS
Aridis Pharmaceuticals
 Nov 23, 2022 BUY Strong Buy
+427319.4% avg upside
5 analysts
$2.00
64416.17% Upside
 -90.1%
VTVT
vTv Therapeutics
 Aug 17, 2022 BUY Strong Buy
-6.9% avg upside
12 analysts
$2.00
94.25% Downside
 -45.4%
AYTU
Aytu BioScience
 May 14, 2020 HOLD Strong Buy
+700.8% avg upside
7 analysts
 — -69.7%
TALO
Talos Energy
 Oct 22, 2018 BUY Strong Buy
+41.8% avg upside
19 analysts
 — -35.0%
BMY
Bristol-Myers Squibb
 Oct 22, 2018 BUY Buy
+9.1% avg upside
42 analysts
$45.00
16.65% Downside
 +10.7%
🔒 17 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Carl Byrnes — Frequently Asked Questions
How accurate are Carl Byrnes's stock ratings?
Based on the calls 13Foresight could measure, about 33% of Carl's ratings were profitable over a one-year hold, with an average return of -22.1% per rating, or -35.5% versus the S&P 500. We score every analyst the same way, from historical prices.
How is Carl ranked on 13Foresight?
Carl Byrnes is currently ranked #2505 with a 1-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Carl cover?
Carl most recently has ratings on CNTB, MDXG, SPRY, RCEL, BLFS, TLSI, MDAI, SNWV, INDV, BWAY, ALVO, HRTX and 10 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.